Aqr Capital Management LLC Atossa Therapeutics, Inc. Transaction History

Aqr Capital Management LLC

  • $71.5 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$0.85 - $1.28 $74,390 - $112,023
-87,518 Reduced 52.45%
79,335 $86,000
Q1 2022

May 16, 2022
SELL
$1.11 - $1.74 $11,012 - $17,262
-9,921 Reduced 5.61%
166,853 $209,000
Q4 2021

Feb 14, 2022
BUY
$1.6 - $3.27 $229,740 - $469,532
143,588 Added 432.68%
176,774 $283,000
Q3 2021

Nov 15, 2021
BUY
$2.89 - $6.4 $95,907 - $212,390
33,186 New
33,186 $108,000

Others Institutions Holding ATOS

# of Institutions
89
Shares Held
26.5M
Call Options Held
466K
Put Options Held
91.8K
View Full List

About ATOSSA THERAPEUTICS, INC.

ATOS Quotes by TradingView
  • Ticker ATOS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 126,624,000
  • Market Cap $130M
  • Description
  • Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It is also developing A...
More about ATOS
Track This Portfolio

Track Aqr Capital Management LLC Portfolio

Follow Aqr Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email